We already demonstrated that AIM2/caspase-1/caspase-4/IL-1α axis in COPD-derived PBMCs drives the release of pro-fibrotic mediators, such as TGF-β [12]. Here, CASP4 is linked to chronic obstructive pulmonary disease.